Komori
Semiannual Report4925HABA LABORATORIES,INC.Chemicals

Semiannual Report — FY2026 H1

What HABA LABORATORIES,INC. reported for the period from 2026-04-01 to 2026-09-30.

How much it says
57Typical
What moved here
17named for the first time
Its own wording
23terms
Which filing this is
37/ 37newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

During the interim consolidated accounting period, ハーバーコスメティクス株式会社 was excluded from the scope of consolidation as a result of an absorption-type merger on 1 April 2026, and we proceeded with measures to improve the efficiency of operations from logistics through sales. At the same time, sales declined year on year, and operating income, ordinary income and interim net income attributable to owners of the parent all decreased substantially.

Komori's summary of this document, not the document's own words.
57Typical
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 36 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
81
Very detailed
Intensity of change
68
Detailed
Strategic shift
97
Very detailed
Capital movement
75
Very detailed
Disclosure gaps
24
Almost nothing
Concentration risk
0
Almost nothing
Change in risk
55
Typical
Financial and capital policy
71
Detailed
Specificity of disclosure
53
Typical
Product Portfolio
35
Thin
Technology position
50
Typical
Confidence in strategic bets
R&D spend70百万円Money spent making new things.
Cash left over-4億円Cash from the business, less what went into equipment.
Spent on equipment2億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
HABA LABORATORIES,INC. — FY2026 H1 | Komori